Cassava Sciences Inc (SAVA)
19.64
-1.55
(-7.31%)
USD |
NASDAQ |
Apr 19, 16:00
19.77
+0.13
(+0.66%)
After-Hours: 20:00
Cassava Sciences Free Cash Flow (Quarterly): -22.36M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -22.36M |
| September 30, 2023 | -26.55M |
| June 30, 2023 | -19.92M |
| March 31, 2023 | -13.61M |
| December 31, 2022 | -20.98M |
| September 30, 2022 | -22.71M |
| June 30, 2022 | -12.58M |
| March 31, 2022 | -23.96M |
| December 31, 2021 | -8.087M |
| September 30, 2021 | -36.80M |
| June 30, 2021 | -5.212M |
| March 31, 2021 | -2.306M |
| December 31, 2020 | -1.175M |
| September 30, 2020 | -2.171M |
| June 30, 2020 | -0.842M |
| March 31, 2020 | -1.194M |
| December 31, 2019 | -0.589M |
| September 30, 2019 | -0.73M |
| June 30, 2019 | -0.591M |
| March 31, 2019 | -0.622M |
| December 31, 2018 | -0.565M |
| September 30, 2018 | -1.436M |
| June 30, 2018 | -1.126M |
| March 31, 2018 | -1.643M |
| December 31, 2017 | -1.437M |
| Date | Value |
|---|---|
| September 30, 2017 | -2.151M |
| June 30, 2017 | -3.197M |
| March 31, 2017 | -1.452M |
| December 31, 2016 | -3.03M |
| September 30, 2016 | -2.863M |
| June 30, 2016 | -3.274M |
| March 31, 2016 | -3.142M |
| December 31, 2015 | -3.548M |
| September 30, 2015 | -2.41M |
| June 30, 2015 | -1.948M |
| March 31, 2015 | -1.342M |
| December 31, 2014 | -2.564M |
| September 30, 2014 | -1.672M |
| June 30, 2014 | -2.591M |
| March 31, 2014 | -2.802M |
| December 31, 2013 | -1.454M |
| September 30, 2013 | -1.819M |
| June 30, 2013 | -1.801M |
| March 31, 2013 | -1.873M |
| December 31, 2012 | -1.854M |
| September 30, 2012 | -1.297M |
| June 30, 2012 | -1.95M |
| March 31, 2012 | -2.07M |
| December 31, 2011 | -0.809M |
| September 30, 2011 | -1.173M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-36.80M
Minimum
Sep 2021
-0.589M
Maximum
Dec 2019
-11.70M
Average
-8.087M
Median
Dec 2021
Free Cash Flow (Quarterly) Benchmarks
| Amylyx Pharmaceuticals Inc | 13.20M |
| MannKind Corp | 15.80M |
| Clearside Biomedical Inc | 0.375M |
| Lantern Pharma Inc | -3.390M |
| NovaBay Pharmaceuticals Inc | -0.316M |